An $816 Million Verdict Survives, and a Small-Firm Trial Team Tests the Limits of Corporate Defense

The expensive part of a lawsuit often arrives long before a jury speaks. Experts must be retained, depositions taken, and years of uncertainty financed without any assurance of recovery. That economic problem is newly visible in Pennsylvania, where an appellate court has left standing a judgment approaching $816 million against Exxon Mobil Corporation in a benzene-exposure case brought by a former service-station mechanic and his wife. For independent trial firms, the ruling concerns something more durable than a headline number: the ability to sustain litigation against a defendant with substantially greater resources.
A Verdict That Endured
On October 15, the Pennsylvania Superior Court upheld a Philadelphia jury's 2024 award of $725.5 million to Paul Gill and Diane Gill. Delay damages imposed by the trial court had increased the judgment to nearly $816 million. Gill, who worked around gasoline and solvents at a Mobil station in the 1970s, alleged that benzene exposure caused his leukemia.
Sources characterized the appellate decision as a significant defeat for Exxon's effort to overturn the exceptionally large award. The result did not settle the broader debate over damages; it resolved the appeal before the judges. Nor is an affirmed judgment necessarily money collected. Further review remains possible.
The plaintiffs' legal team included Andrew DuPont of Locks Law Firm, alongside Patrick Wigle and Rajeev Mittal of Waters Kraus Paul & Siegel. In its September 2024 announcement following the trial court's ruling, Locks called the outcome "a major victory for the plaintiffs." The statement reflected the firm's position at that stage, before the appellate proceedings brought the dispute back into focus.
The Dispute Behind the Number
The appeal concerned medical causation, warnings and the extraordinary size of the award. The Pennsylvania Record reported that Exxon questioned the evidence connecting gasoline exposure to Gill's leukemia and raised concerns about a juror's public comments following the trial.
The appellate court found that certain arguments had not been properly preserved and that Exxon's effort to raise the juror issue came too late.
Business organizations, including the U.S. Chamber of Commerce, had urged reversal, arguing that unusually large noneconomic awards could distort settlement incentives and impose costs beyond individual disputes. Their objections underscore a tension frequently absent from accounts of successful plaintiff litigation: an award can survive judicial scrutiny while remaining deeply contested as a measure of compensation.

The Economics of Taking on a Giant
For a midsize partnership, the lesson is not that toxic-tort litigation routinely produces extraordinary returns. It is that specialized firms can combine trial capabilities without recreating the overhead of a national full-service practice.
Co-counsel arrangements can distribute expertise and financial exposure while preserving each firm's independence. But they require careful agreements over expenses, staffing, strategic control and eventual fee division, consistent with professional-responsibility requirements.
The financial risks are substantial. Contingency litigation may demand years of lawyer time, expert expenditures and operating capital before producing any collectible recovery. Unlike hourly commercial litigation, there may be no regular payments to support the partnership during that period.
Client relationships introduce another uncertainty. An attorney's trial reputation may generate referrals, but future instructions are neither guaranteed nor automatically transferable. Trust must survive prolonged litigation, appeals and disputes over costs.
The competitive distinction matters. Large defense firms can mobilize substantial personnel and institutional resources. Narrow plaintiff boutiques can concentrate on particular injuries or industries. A midsize firm occupies the territory between them, with enough capacity to manage complex proceedings but without the same tolerance for prolonged financial uncertainty.
The Pennsylvania ruling strengthens the Gills' position without eliminating the costs and uncertainties ahead. For founding partners, the more consequential distinction may be the distance between obtaining a verdict, collecting a judgment and building a practice capable of financing the next case.

